Lv2
125 积分 2021-01-17 加入
Anticoagulation Medications, Monitoring, and Outcomes in Patients with Cardiogenic Shock Requiring Temporary Mechanical Circulatory Support
12天前
已完结
Efficacy and Safety of Anti-Xa-Guided Versus Fixed Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism in Trauma Patients
16天前
已完结
Monitoring anti‐Xa levels in elderly medical patients undergoing thromboprophylaxis: A prospective cohort study
21天前
已完结
Evaluation of anti-XA-guided versus APTT-guided management of intravenous unfractionated heparin in patients requiring a durable ventricular assist device
21天前
已完结
Evaluation of anti-XA-guided versus APTT-guided management of intravenous unfractionated heparin in patients requiring a durable ventricular assist device
21天前
已关闭
Analysis of the 2020 EACTS/ELSO/STS/AATS Expert Guidelines on the Management of Adult Postcardiotomy Extracorporeal Life Support
1个月前
已完结
Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO Study
1个月前
已完结
Cost Effectiveness of Anticoagulation in Acute Coronary Syndromes
1个月前
已完结
Role of anticoagulation in non-ST-elevation myocardial infarction: a contemporary narrative review
1个月前
已完结
Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins
1个月前
已完结
皖公网安备34019202002308
